APP下载

静脉滴注阿奇霉素致儿童药物性肝损伤的临床特征及影响因素分析

2025-11-16李婉慧吕晓倩苏丹霍保凤陈赫军闫平

中国药房 2025年20期

中图分类号 R985;R978.1;R969.3 文献标志码A 文章编号 1001-0408(2025)20-2566-05

DOI10.6039/j.issn.1001-0408.2025.20.14

Analysisofclinical characteristicsand influential factorsof drug-induced liver injuryinchildrencaused by intravenousazithromycin

LI Wanhui',LYU Xiaoqian’,SU Dan’,HUO Baofeng,CHEN Hejun²,YAN Ping1(1. Dept.of Pediatric Internal Medicine,Hengshui People’sHospital,Hebei Hengshui O530O0,China;2.Dept.of Pharmacy,Hengshui People'sHospital,Hebei Hengshui O53000,China)

ABSTRACTOBJECTIVEToanalyze theclinicalcharacteristicsand influential factorsof drug-inducedliver injury(DILI)in childrencausedbyintravenousazithromycin.METHODsClinical dataof157DILI pediatriccasescausedbyintravenous azithromycin,reportedbythe Hengshui AdverseDrugReactionMonitoring Centerfrom January2O15toJanuary2025,were collctedastheobservationgroup.Clinical dataof pediatricpatients whoreceivedintravenous azithromycinbutdidnotdevelop DILIduringthesameperiodatHengshuiPeople’sHospitalwerecolectedina1:1ratiotoserveasthecontrolgroup.Theclinical clasification,severityandprognosisofDILIinpediatricpatientsfromtheobservationgroupwereanalyzedUnivariateand multivariateLogisticregressonanalyseswereusedtosreetheindependentrisfactorsforDIIinchildrencausedbyintravenous azithromycin. RESULTS Among 157 DILI cases,92 cases( 58.60% )had hepatocellular injury-type,51 cases( 32.48% )had cholestatic-type,and 14 cases ( 8.92% )had mixed-type.DILI severitywas grade1in117 cases( 74.52% ),grade2in 33cases (20 (21.02% ),andgrade3in7cases( 4.46% ).Liver function had all recovered after stopping medication and symptomatic treatment. Combined with acetaminophen [OR =3.769 , 95%CI (1.615,8.235), P=0.021] ,daily dose of azithromycin gt;10mg/kg [OR 2.237, 95%CI (1.075,4.655), P=0.034. were independent risk factors for DILI in children caused by intravenous azithromycin. CONCLUSIONS Hepatocelularijury-typeandcholestatic-typearerelativelycommon inchildren withDLIcausedbyintravenous azithromycin,with mild severity being predominantand showingafavorable prognosis.Combination withacetaminophenanddaily

do segt;10mg/kg areindependent risk factors for azithromycininduced DILI in children.

KEYWORDSazithromycin;drug-induced liver injury;children; clinicalcharacteristics;influential factors

阿奇霉素是临床应用广泛的大环内酯类抗菌药物,是治疗非典型病原体、细菌感染的常用药物之一。然而,随着该药临床应用的日益广泛,其所致药物性肝损伤(drug-inducedliverinjury,DILI)也备受临床关注。美国一项调查显示,每10万例使用阿奇霉素的患者中,有20例会发生DILI,发生率为 0.02%[1] 。尽管阿奇霉素致DILI的发生率相对较低,但其起病较为隐匿:在疾病早期,患者并无明显临床症状,且缺乏特异性表现,仅可见肝功能指标异常,易被临床误诊;而严重者可进展为肝功能衰竭,甚至死亡[]。Conlon等对美国DILI网络收录的30例阿奇霉素致DILI患者的临床预后进行分析后发现, 17% 的患者进展为慢性肝功能不全,其中2例需要肝移植、1例死于肝功能衰竭。Liang等4报道,尽管阿奇霉素已被证实是一种相对安全的抗菌药物,但DILI是其罕见且潜在的致命副作用之一。

儿童是阿奇霉素的主要用药人群。儿童作为一个特殊的用药群体,由于生理功能尚未发育完善,免疫功能较低下,对外界侵袭的防御能力较差,故较成人更易发生DILI。儿童DILI的临床表现多样,症状多不典型;部分年龄较小的患儿因无法表述自身的病情及自觉症状,使得儿童DILI难以被临床早期识别,从而增加DILI预后不良的风险[。由此可见,早识别阿奇霉素致儿童DILI的临床特征并及时进行有效干预,可有助于减少药源性不良反应的发生、保证患儿用药安全。此外,相较于非静脉滴注给药方式,静脉滴注给药途径致不良反应的发生率和严重程度更高;……

登录APP查看全文